302 resultados para apache
Resumo:
El objetivo de este proyecto es el desarrollo de una aplicación móvil para dispositivos con sistema operativo Android que permita la búsqueda de ofertas de hotel de una forma diferente a las actuales. Para ello se ha empleado el modelo del ciclo de vida en cascada, con las fases de análisis, diseño, construcción y pruebas del sistema desarrollado. El software final sigue una arquitectura de tipo cliente/servidor y ha sido realizado con Java como lenguaje base de programación, haciendo uso de algunas librerías como Apache HTTP Request para las conexiones con el servidor remoto como las propias de Android, que facilitan la creación de interfaces gráficas y la gestión de los recursos de los dispositivos en el desarrollo de aplicaciones móviles.
Resumo:
El proyecto consiste en la realización de una agenda web modular, utilizando para ello las tecnologías de la plataforma J2EE mediante frameworks (Hibernate y Spring) y un patrón de arquitectura (MVC). La agenda se ha realizado para ser gestionada por un servidor Apache Tomcat y sus datos almacenados en MySQL.
Resumo:
GeoPost-it es una aplicación móvil para insertar notas privadas y públicas basadas en la posición del dispositivo.
Resumo:
La finalitat d'aquest projecte és la creació d'una aplicació que faci les funcions d'una Autoritat de Certificació (CA) dins del marc d'una Infraestructura de Clau Pública (PKI). Aquesta aplicació té una interfície web que ofereix una sèrie de serveis en línia.Les operacions que ofereix seran de dos tipus:- Públiques: d'accés obert i que permet obtenir certificats mitjançant fitxers de petició PKCS#10 o introduint les dades de l'usuari. També permet descarregar la Llista de Revocació de Certificats (CRL) i el certificat arrel de la CA.- Privades: on l'usuari s'haurà d'autenticar prèviament com a administrador, ja sigui amb una connexió local i l'ús d'un nom d'usuari i una contrasenya o amb la presentació d'un certificat autoritzat. Les funcions que es podran dur a terme inclouen la posada en marxa de l'aplicació, la seva reinicialització, la gestió de drets d'administrador, la consulta de certificats, la revocació d'aquests o la publicació de la CRL.Les operacions internes de l'aplicació estan separades de la interfície amb l'objectiu de que es puguin fer servir des d'un altre programari.El producte ha estat desenvolupat en llenguatge Java i s'executa mitjançant un contenidor de servlets Apache Tomcat sobre Linux (tot i que seria fàcilment portable a altres contenidors i sistemes operatius). Es fa servir una base de dades MySQL per emmagatzemar la informació de l'aplicació.L'objectiu del projecte és aprofundir en els coneixements sobre Infraestructures de Clau Pública i en les funcions i serveis que ha d'oferir una Autoritat de Certificació, posant un especial èmfasi en tot el referent a la seguretat del sistema.
Resumo:
Aplicació mòbil per als aficionats a la micologia, implementada en PHP5, MySQL i servidor Apache.
Resumo:
Enteral nutrition (EN) via tube feeding is, today, the preferred way of feeding the critically ill patient and an important means of counteracting for the catabolic state induced by severe diseases. These guidelines are intended to give evidence-based recommendations for the use of EN in patients who have a complicated course during their ICU stay, focusing particularly on those who develop a severe inflammatory response, i.e. patients who have failure of at least one organ during their ICU stay. These guidelines were developed by an interdisciplinary expert group in accordance with officially accepted standards and are based on all relevant publications since 1985. They were discussed and accepted in a consensus conference. EN should be given to all ICU patients who are not expected to be taking a full oral diet within three days. It should have begun during the first 24h using a standard high-protein formula. During the acute and initial phases of critical illness an exogenous energy supply in excess of 20-25 kcal/kg BW/day should be avoided, whereas, during recovery, the aim should be to provide values of 25-30 total kcal/kg BW/day. Supplementary parenteral nutrition remains a reserve tool and should be given only to those patients who do not reach their target nutrient intake on EN alone. There is no general indication for immune-modulating formulae in patients with severe illness or sepsis and an APACHE II Score >15. Glutamine should be supplemented in patients suffering from burns or trauma.
Resumo:
Argatroban has been introduced as an alternative parenteral anticoagulant for HIT-patients in several European countries in 2005. In 2009 a panel of experts discussed their clinical experience with argatroban balancing risks and benefits of argatroban treatment in managing the highly procoagulant status of HIT-patients. This article summarizes the main conclusions of this round table discussion. An ongoing issue is the appropriate dosing of argatroban in special patient groups. Therefore, dosing recommendations for different HIT-patient groups (ICU patients; non-ICU patients, paediatric patients, and for patients undergoing renal replacement therapies) are summarized in this consensus statement. Because of the strong correlation between argatroban dosing requirements and scores used to characterize the severity of illness (APACHE; SAPS, SOFA) suitable dosing nomograms are given. This consensus statement contributes to clinically relevant information on the appropriate use and monitoring of argatroban based on the current literature, and provides additional information from clinical experience. As the two other approved drugs for HIT, danaparoid and lepirudin are either currently not available due to manufacturing problems (danaparoid) or will be withdrawn from the market in 2012 (lepirudin), this report should guide physicians who have limited experience with argatroban how to use this drug safely in patients with HIT.
Resumo:
The fully human anti-lipopolysaccharide (LPS) immunoglobulin M (IgM) monoclonal antibody panobacumab was developed as an adjunctive immunotherapy for the treatment of O11 serotype Pseudomonas aeruginosa infections. We evaluated the potential clinical efficacy of panobacumab in the treatment of nosocomial pneumonia. We performed a post-hoc analysis of a multicenter phase IIa trial (NCT00851435) designed to prospectively evaluate the safety and pharmacokinetics of panobacumab. Patients treated with panobacumab (n = 17), including 13 patients receiving the full treatment (three doses of 1.2 mg/kg), were compared to 14 patients who did not receive the antibody. Overall, the 17 patients receiving panobacumab were more ill. They were an average of 72 years old [interquartile range (IQR): 64-79] versus an average of 50 years old (IQR: 30-73) (p = 0.024) and had Acute Physiology and Chronic Health Evaluation II (APACHE II) scores of 17 (IQR: 16-22) versus 15 (IQR: 10-19) (p = 0.043). Adjunctive immunotherapy resulted in an improved clinical outcome in the group receiving the full three-course panobacumab treatment, with a resolution rate of 85 % (11/13) versus 64 % (9/14) (p = 0.048). The Kaplan-Meier survival curve showed a statistically significantly shorter time to clinical resolution in this group of patients (8.0 [IQR: 7.0-11.5] versus 18.5 [IQR: 8-30] days in those who did not receive the antibody; p = 0.004). Panobacumab adjunctive immunotherapy may improve clinical outcome in a shorter time if patients receive the full treatment (three doses). These preliminary results suggest that passive immunotherapy targeting LPS may be a complementary strategy for the treatment of nosocomial O11 P. aeruginosa pneumonia.
Resumo:
Take me away és un projecte SIG orientat a desenvolupar una aplicació mòbil per a Android que permeti cercar rutes de viatge coincidents de manera geogràfica amb l'objectiu final que els usuaris es posin en contacte per tal de compartir el transport privat i els recursos que l'engloben.
Resumo:
With nearly 2,000 free and open source software (FLOSS) licenses, software license proliferation¿ can be a major headache for software development organizations trying to speed development through software component reuse, as well as companies redistributing software packages as components of their products. Scope is one problem: from the Free Beer license to the GPL family of licenses to platform-specific licenses such as Apache and Eclipse, the number and variety of licenses make it difficult for companies to ¿do the right thing¿ with respect to the software components in their products and applications. In addition to the sheer number of licenses, each license carries within it the author¿s specific definition of how the software can be used and re-used. Permissive licenses like BSD and MIT make it easy; software can be redistributed and developers can modify code without the requirement of making changes publicly available. Reciprocal licenses, on the other hand, place varying restrictions on re-use and redistribution. Woe to the developer who snags a bit of code after a simple web search without understanding the ramifications of license restrictions.
Resumo:
Este trabajo ha tenido como objetivo la realización de una aplicación para móviles desarrollada en HTML5 llamada ¿Audioguía Turística de El Real Monasterio de San Lorenzo de El Escorial¿.Se han utilizado tecnologías como HTML5, javascript, jQuery Mobile (framework de javascritp), CSS, ThemRoller, y Phonegap (ahora apache Cordoba). También se ha usado Eclipse como IDE para el desarrollo con el pluging de Aptana.Se ha logrado una aplicación instalable en cualquier dispositivo móvil (Smartphone) o Tablet de cualquier tamaño, obteniéndose una app multidispositivo de tipo híbrida que puede usar y disponer de los recursos que posee el teléfono móvil como hacer llamadas, geolocalización, etc. Aparte de todo ello, para alcanzar una app multiplataforma se ha usado Phonegap Build, proporcionándonos con la compilación en la nube varios archivos instalables en distintas plataformas como Android, Windows-Phone, etc. Por tanto, se ha obtenido el desarrollo de una aplicación con HTML5 multidispositivo y multiplataforma.
Resumo:
Background: Development of three classification trees (CT) based on the CART (Classification and Regression Trees), CHAID (Chi-Square Automatic Interaction Detection) and C4.5 methodologies for the calculation of probability of hospital mortality; the comparison of the results with the APACHE II, SAPS II and MPM II-24 scores, and with a model based on multiple logistic regression (LR). Methods: Retrospective study of 2864 patients. Random partition (70:30) into a Development Set (DS) n = 1808 and Validation Set (VS) n = 808. Their properties of discrimination are compared with the ROC curve (AUC CI 95%), Percent of correct classification (PCC CI 95%); and the calibration with the Calibration Curve and the Standardized Mortality Ratio (SMR CI 95%). Results: CTs are produced with a different selection of variables and decision rules: CART (5 variables and 8 decision rules), CHAID (7 variables and 15 rules) and C4.5 (6 variables and 10 rules). The common variables were: inotropic therapy, Glasgow, age, (A-a)O2 gradient and antecedent of chronic illness. In VS: all the models achieved acceptable discrimination with AUC above 0.7. CT: CART (0.75(0.71-0.81)), CHAID (0.76(0.72-0.79)) and C4.5 (0.76(0.73-0.80)). PCC: CART (72(69- 75)), CHAID (72(69-75)) and C4.5 (76(73-79)). Calibration (SMR) better in the CT: CART (1.04(0.95-1.31)), CHAID (1.06(0.97-1.15) and C4.5 (1.08(0.98-1.16)). Conclusion: With different methodologies of CTs, trees are generated with different selection of variables and decision rules. The CTs are easy to interpret, and they stratify the risk of hospital mortality. The CTs should be taken into account for the classification of the prognosis of critically ill patients.
Resumo:
BACKGROUND: Normobaric oxygen therapy is frequently applied in neurocritical care, however, whether supplemental FiO2 has beneficial cerebral effects is still controversial. We examined in patients with severe traumatic brain injury (TBI) the effect of incremental FiO2 on cerebral excitotoxicity, quantified by cerebral microdialysis (CMD) glutamate. METHODS: This was a retrospective analysis of a database of severe TBI patients monitored with CMD and brain tissue oxygen (PbtO2). The relationship of FiO2-categorized into four separate ranges (<40, 41-60, 61-80, and >80 %)-with CMD glutamate was examined using ANOVA with Tukey's post hoc test. RESULTS: A total of 1,130 CMD samples from 36 patients-monitored for a median of 4 days-were examined. After adjusting for brain (PbtO2, intracranial pressure, cerebral perfusion pressure, lactate/pyruvate ratio, Marshall CT score) and systemic (PaCO2, PaO2, hemoglobin, APACHE score) covariates, high FiO2 was associated with a progressive increase in CMD glutamate [8.8 (95 % confidence interval 7.4-10.2) µmol/L at FiO2 < 40 % vs. 12.8 (10.9-14.7) µmol/L at 41-60 % FiO2, 19.3 (15.6-23) µmol/L at 61-80 % FiO2, and 22.6 (16.7-28.5) µmol/L at FiO2 > 80 %; multivariate-adjusted p < 0.05]. The threshold of FiO2-related increase in CMD glutamate was lower for samples with normal versus low PbtO2 < 20 mmHg (FiO2 > 40 % vs. FiO2 > 60 %). Hyperoxia (PaO2 > 150 mmHg) was also associated with increased CMD glutamate (adjusted p < 0.001). CONCLUSIONS: Incremental normobaric FiO2 levels were associated with increased cerebral excitotoxicity in patients with severe TBI, independent from PbtO2 and other important cerebral and systemic determinants. These data suggest that supra-normal oxygen may aggravate secondary brain damage after severe TBI.
Resumo:
Trabajo final de carrera en el área de ingeniería del software donde se realiza el análisis y diseño de una solución tecnológica que cubra las necesidades de gestión de una pequeña empresa, en concreto de un centro de belleza.
Resumo:
Desenvolupament d'un cercador telefònic pels empleats d'una empresa de més de 3000 treballadors.